Recent Updates
Recently added Catalysts
ATOS Positive Sentiment Score: 70/100

Atossa Therapeutics to Present at the 2024 Maxim Healthcare Virtual Summit

Monday, October 14, 2024 1 min read
Key Takeaway: Atossa Therapeutics, Inc. announced that Michael Parks, the Vice President of Investor and Public Relations, will participate in a virtual fireside chat at the 2024 Maxim Healthcare Virtual Summit on October 16, 2024. The company, which operates in the clinical-stage biopharmaceutical sector, specializes in developing innovative treatments for oncology, particularly breast cancer. Interested individuals can access the conference through a live webcast. Atossa is dedicated to addressing significant unmet medical needs in cancer treatments.

Market Sentiment Analysis

POSITIVE FACTORS

  • Atossa Therapeutics is actively participating in a prominent industry event.
  • The company is focused on developing innovative medicines for significant unmet medical needs in oncology.
  • Their focus on breast cancer signifies a commitment to addressing critical health issues.

Full Press Release Details

SEATTLE, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), today announced that Michael Parks, Vice President, Investor and Public Relations, will participate in a virtual fireside chat on Wednesday, October 16, 2024 at 12:00 p.m. EDT at the 2024 Maxim Healthcare Virtual Summit. Atossa is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer.
Interested parties can register and access the live webcast for the conference here.
About Atossa Therapeutics
Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on using (Z)-endoxifen to prevent and treat breast cancer. For more information, please visit www.atossatherapeutics.com.
Vice President, Investor and Public Relations
michael.parks@atossainc.com

Frequently Asked Questions

What is the date of the virtual fireside chat?

The virtual fireside chat is on October 16, 2024.

Who will represent Atossa Therapeutics in the chat?

Michael Parks will represent Atossa Therapeutics.

What area does Atossa Therapeutics specialize in?

Atossa Therapeutics specializes in oncology, focusing on breast cancer.

How can I access the live webcast?

Interested parties can register for the live webcast online.

What is the focus of Atossa's development?

Atossa focuses on innovative medicines for significant unmet medical needs.

Tags: ATOS Viatris Investor Conferences Healthcare breast cancer oncology 2024 summit biopharmaceutical
Last updated: Oct 14, 2024